Axalta Coating Systems

▲ Bull Case

• ◆Deal closes mid-2027, synergies overshoot conservative $600M target (SHW-Valspar precedent), combined company re-rates to 12x EV/EBITDA premium on #1 global coatings rarity; AXTA per-share PV reaches $68 (+120%)
• ◆ADAS-driven collision-frequency bear case definitively falsified by Q1 2026 data; Refinish volume stabilizes or turns positive driven by complexity-per-repair growth (sensor calibration, multi-panel work) overwhelming frequency decline; Performance Coatings margins expand to 27%+
• ◆Axalta deploys $250M+ to repurchases between announcement and close (vs. $100M/year historical pace) given >$500M FY2026 FCF guidance and on-target 2.3x leverage; share count reduction accretes EPS for remaining holders at 0.6539 exchange ratio

▼ Bear Case

• ◆EU antitrust review blocks deal or forces large carve-outs (>$500M revenue, e.g., entire Sikkels or Standox brand); destroys synergy denominator and kills transaction or strips deal-close probability; AXTA reverts to standalone $30-35 with failed-deal stigma multiple
• ◆Refinish volume turns persistently negative as ADAS-equipped 2019-2022 vehicles hit peak collision years; -2 to -3% volume declines FY27 onward; Performance Coatings EBITDA margin compresses 200-300 bps; combined-co re-rates to 8.5x; AXTA per-share PV drops to $32-36
• ◆Synergy execution disappoints via cross-Atlantic culture integration friction (Bermuda/US/Netherlands), CEO succession complexity (Villavarayan Deputy, not CEO), industrial coatings proving less synergistic; $600M target achieves only 60-70% over 4-5 years vs. 90% in 3

“The Street's active debate centers on deal-close probability and synergy quality, not standalone fundamentals. Bulls argue antitrust is manageable (multiple credible global competitors; carve-outs unlikely >$200-300M); $600M synergies credible given cost-overlap structure; both shareholder bases will approve—implied deal-close probability 85-90%. Bears argue EU historically demands aggressive divestitures in specialty chemicals (Dow-DuPont precedent); AKZA's €2.5B special dividend pre-close is dilutive to combined NAV; Villavarayan as Deputy CEO signals AXTA got worse deal; integration execution risk material—implied deal-close probability 65-75%. Our weighting: 85% across deal-close scenarios; 15% severe deal-break. Mid-2026 EGM shareholder votes will be the first material data point to update this calculation.”

• ◆Mid-2026 EGM shareholder votes (AXTA and AKZA)—binary deal-momentum catalyst; positive vote significantly de-risks close probability
• ◆EU and US antitrust filings and approvals (H2 2026)—clearance with manageable carve-outs (<$300M revenue) compresses deal-spread to <5%
• ◆Deal close (late 2026 / early 2027)—converter event; AXTA holders receive AKZA shares at 0.6539 ratio; combined company begins trading
• ◆First combined-company quarterly results (post-close)—initial synergy progress markers and multiple expansion/compression catalyst
• ◆Standalone Q2 and Q3 2026 earnings—Refinish volume trajectory and EBITDA margin progress inform both standalone fallback and combined-co base case
• ◆Continued share buyback execution during pendency—$250M+ deployment at $30-32 per share vs. 0.6539 exchange ratio creates accretive math for remaining holders
• ◆CEO transition and integration signals—public commentary from Villavarayan and AKZA's Poux-Guillaume on integration approach and cultural alignment

• ◆EU antitrust review blocks deal or forces large carve-outs (>$500M revenue)—highest-impact tail risk (~10-15% probability); destroys synergy case or kills transaction entirely
• ◆AXTA or AKZA shareholders vote against deal at mid-2026 EGMs (~5% probability); activist intervention most realistic opposition vehicle
• ◆Material adverse change between announcement and close (macro shock, auto cycle downturn, raw material spike) triggers walk-away clauses
• ◆Synergy realization slips materially post-close—low near-term impact, larger impact on 2-year combined-company multiple and NPV
• ◆ADAS-driven Refinish volume decline accelerates in FY27-FY28 (structural risk affecting both standalone fallback and combined-company EBITDA base)
• ◆Raw material cost spike (TiO2 supply disruption from Tronox/Venator, Chinese export controls)—$50-100M EBITDA tail risk
• ◆Cross-border integration friction—Bermuda/Pennsylvania/Netherlands governance complexity, CEO dual-leadership tensions, IT systems consolidation delays
• ◆Interest rate environment—combined company refinancing needs in 2027-2029 sensitive to rate moves; higher rates increase combined-co WACC and reduce NPV